tirzepatide fda approval for weight loss Lilly's Zepbound (aka tirzepatide) Lands What to Expect on Tirzepatide:

Embrace this period as an opportunity to fine-tune your lifestyle for sustainable weight management

Early stomach-related issues tend to ease as the dosage settles

In this trial, the majority of subjects did not have established CVD at baseline, and the highly anticipated results from the trial will add to the body of evidence on the potential role for GLP-1RAs on CV risk reduction in a broad range of individuals with T2D [38]

For patients requiring surgical procedures, recent 2024 multi-society guidance (including the American Society of Anesthesiologists) indicates that most patients can continue GLP-1 receptor agonists perioperatively

For Ozempic, the FDA-approved escalation schedule begins at 0.25 mg weekly for 4 weeks, increases to 0.5 mg for at least 4 weeks, then may increase to 1 mg and potentially 2 mg based on glycemic response